个人中心 - 老虎社区

Dorash

IP属地：湖北

帖子 · 17帖子 · 17
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- DorashDorash
  ·2021-03-31
  不错
  非常抱歉，此主贴已删除
  1,229 评论
  点赞
  分享
  举报
- DorashDorash
  ·2021-03-24
  文章说q1今年收入1千万
  Kindred Biosciences (KIN) Reports Q4 Loss, Lags Revenue Estimates
  Kindred Biosciences (KIN) came out with a quarterly loss of $0.28 per share versus the Zacks Consens
  Kindred Biosciences (KIN) Reports Q4 Loss, Lags Revenue Estimates
  1,323 评论
  点赞
  分享
  举报
- DorashDorash
  ·2021-03-24
  为啥这两只刚好是我买入的，目前浮亏一成了！
  These 2 Penny Stocks Could Rally All the Way to $11, Say Analysts
  At its January FOMC meeting, the Federal Reserve held interest rates steady – they are near rock-bot
  These 2 Penny Stocks Could Rally All the Way to $11, Say Analysts
  1,516 评论
  点赞
  分享
  举报
- DorashDorash
  ·2020-11-25
  $盈透证券(IBKR)$换了工作，结果绑的扣扣邮箱不能换手机号，因为手机已经注销了，然后年底想取钱，结果告知被冻结了，取不出来了。儿子叒生病了，不知道什么时候好，现在回了国外那边邮件，啥时候能把钱转出来呢！大家有这种情况吗？
  3,751 3
  点赞
  分享
  举报
- DorashDorash
  ·2020-09-21
  本来以为卖了美股就安全了，可是其他a股h也下跌啊
  盘前：道指期货跌2%！避险情绪升温，美股迎惊魂一夜
  9月21日（周一），美股三大指数期货全线下跌，道指期货跌近2%。【盘前行情】热门中概股热门中概股普跌，蔚来、理想、哔哩哔哩、百度、京东跌超2%、阿里跌1.62%。京东盘前跌超2%，子公司京东健康将
  盘前：道指期货跌2%！避险情绪升温，美股迎惊魂一夜
  1,841 评论
  2
  分享
  举报
- DorashDorash
  ·2020-06-08
  $枫叶教育(01317)$不错不错，值得关注！
  1,395 评论
  4
  分享
  举报
- DorashDorash
  ·2019-12-28
  $老虎证券(TIGR)$买这种股票到底是图啥？大资金会来解放我们吗？现在市场管制，突然业绩爆发可能性没有，然后美股年年新高，抄底资金没有，周期高点啊！哪个高手谈下买入理由！
  2,966 1
  4
  分享
  举报
- DorashDorash
  ·2019-12-11
  $中兴通讯(00763)$同为5g概念你为啥不知道涨？看看人家立讯精密！！！
  3,050 1
  2
  分享
  举报
- DorashDorash
  ·2019-12-11
  $小米集团-W(01810)$这种好的有业绩的还有利润的，还是知名的，还在增长的，腰斩就是黄金坑啊！
  3,001 1
  5
  分享
  举报
- DorashDorash
  ·2019-12-10
  $小米集团-W(01810)$K30在哪里买啊？官网还看不到！
  2,169 2
  2
  分享
  举报
暂无粉丝

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

老虎社区侵权投诉指引

中国互联网举报中心·北京互联网举报中心

网络谣言曝光台·扫黄打非举报中心

网络110报警服务

© 2018-2024 老虎社区版权所有

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

qrcode

关注我们

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3464149602391943","uuid":"3464149602391943","gmtCreate":1501055582561,"gmtModify":1502690323634,"name":"Dorash","pinyin":"dorash","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":31,"tweetSize":17,"questionSize":0,"limitLevel":900,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.14","exceedPercentage":"93.21%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.03%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"湖北","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":354661149,"gmtCreate":1617167599781,"gmtModify":1617167599781,"author":{"id":"3464149602391943","authorId":"3464149602391943","name":"Dorash","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3464149602391943","idStr":"3464149602391943"},"themes":[],"htmlText":"不错","listText":"不错","text":"不错","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/354661149","repostId":"1168244531","repostType":2,"isVote":1,"tweetType":1,"viewCount":1229,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":351885004,"gmtCreate":1616584915408,"gmtModify":1616584915408,"author":{"id":"3464149602391943","authorId":"3464149602391943","name":"Dorash","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3464149602391943","idStr":"3464149602391943"},"themes":[],"htmlText":"文章说q1今年收入1千万","listText":"文章说q1今年收入1千万","text":"文章说q1今年收入1千万","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/351885004","repostId":"2120700679","repostType":2,"repost":{"id":"2120700679","pubTimestamp":1615930509,"share":"https://www.laohu8.com/m/news/2120700679?lang=&edition=full","pubTime":"2021-03-17 05:35","market":"us","language":"en","title":"Kindred Biosciences (KIN) Reports Q4 Loss, Lags Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2120700679","media":"Zacks","summary":"Kindred Biosciences (KIN) came out with a quarterly loss of $0.28 per share versus the Zacks Consens","content":"<html><body><p>Kindred Biosciences (KIN) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.40 per share a year ago. These figures are adjusted for non-recurring items.</p>\n<p>This quarterly report represents an earnings surprise of 15.15%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $0.31 per share when it actually produced a loss of $0.31, delivering no surprise.</p>\n<p>Over the last four quarters, the company has surpassed consensus EPS estimates two times.</p>\n<p>Kindred Bio, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $0.95 million for the quarter ended December 2020, missing the Zacks Consensus Estimate by 0.94%. This compares to year-ago revenues of $1.4 million. The company has topped consensus revenue estimates two times over the last four quarters.</p>\n<p>The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.</p>\n<p>Kindred Bio shares have added about 13.7% since the beginning of the year versus the S&amp;P 500's gain of 5%.</p>\n<p><b>What's Next for Kindred Bio?</b></p>\n<p>While Kindred Bio has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?</p>\n<p>There are no easy answers to this key question, but <a href=\"https://laohu8.com/S/AONE\">one</a> reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.</p>\n<p>Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.</p>\n<p>Ahead of this earnings release, the estimate revisions trend for Kindred Bio was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.</p>\n<p>It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.33 on $11.9 million in revenues for the coming quarter and -$1.14 on $41.2 million in revenues for the current fiscal year.</p>\n<p>Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the bottom 29% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.</p>\n<br/>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n<br/> \n<br/>\n<a href=\"https://laohu8.com/S/KIN\">Kindred Biosciences, Inc.</a> (KIN) : Free Stock Analysis Report\n<br/> \n<br/>\nTo read this article on Zacks.com click here.\n<br/> \n<br/>\nZacks Investment Research</body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kindred Biosciences (KIN) Reports Q4 Loss, Lags Revenue Estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKindred Biosciences (KIN) Reports Q4 Loss, Lags Revenue Estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-17 05:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/kindred-biosciences-kin-reports-q4-213509431.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Kindred Biosciences (KIN) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.40 per share a year ago. These figures ...</p>\n\n<a href=\"https://finance.yahoo.com/news/kindred-biosciences-kin-reports-q4-213509431.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/88Fg6KE6GPnh0zlh3tqRTA--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/9naTdeJlVMX28sdlDpLdrQ--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ac90b3d74679f6d01a122aa033d8a9a4","relate_stocks":{"KIN":"Kindred Biosciences, Inc."},"source_url":"https://finance.yahoo.com/news/kindred-biosciences-kin-reports-q4-213509431.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2120700679","content_text":"Kindred Biosciences (KIN) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.40 per share a year ago. These figures are adjusted for non-recurring items.\nThis quarterly report represents an earnings surprise of 15.15%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $0.31 per share when it actually produced a loss of $0.31, delivering no surprise.\nOver the last four quarters, the company has surpassed consensus EPS estimates two times.\nKindred Bio, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $0.95 million for the quarter ended December 2020, missing the Zacks Consensus Estimate by 0.94%. This compares to year-ago revenues of $1.4 million. The company has topped consensus revenue estimates two times over the last four quarters.\nThe sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.\nKindred Bio shares have added about 13.7% since the beginning of the year versus the S&P 500's gain of 5%.\nWhat's Next for Kindred Bio?\nWhile Kindred Bio has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?\nThere are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.\nEmpirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.\nAhead of this earnings release, the estimate revisions trend for Kindred Bio was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.\nIt will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.33 on $11.9 million in revenues for the coming quarter and -$1.14 on $41.2 million in revenues for the current fiscal year.\nInvestors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the bottom 29% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n \n\nKindred Biosciences, Inc. (KIN) : Free Stock Analysis Report\n \n\nTo read this article on Zacks.com click here.\n \n\nZacks Investment Research","news_type":1},"isVote":1,"tweetType":1,"viewCount":1323,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":351083321,"gmtCreate":1616545959663,"gmtModify":1616545959663,"author":{"id":"3464149602391943","authorId":"3464149602391943","name":"Dorash","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3464149602391943","idStr":"3464149602391943"},"themes":[],"htmlText":"为啥这两只刚好是我买入的，目前浮亏一成了！","listText":"为啥这两只刚好是我买入的，目前浮亏一成了！","text":"为啥这两只刚好是我买入的，目前浮亏一成了！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/351083321","repostId":"2107260553","repostType":2,"repost":{"id":"2107260553","pubTimestamp":1611851471,"share":"https://www.laohu8.com/m/news/2107260553?lang=&edition=full","pubTime":"2021-01-29 00:31","market":"us","language":"en","title":"These 2 Penny Stocks Could Rally All the Way to $11, Say Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2107260553","media":"TipRanks","summary":"At its January FOMC meeting, the Federal Reserve held interest rates steady – they are near rock-bot","content":"<div>\n<p>At its January FOMC meeting, the Federal Reserve held interest rates steady – they are near rock-bottom now, and to no one’s surprise, the Fed is keeping them there.\nFed Chairman Jerome Powell may ...</p>\n\n<a href=\"https://finance.yahoo.com/news/2-penny-stocks-could-rally-163111780.html\">Web Link</a>\n\n</div>\n","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 2 Penny Stocks Could Rally All the Way to $11, Say Analysts</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 2 Penny Stocks Could Rally All the Way to $11, Say Analysts\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-01-29 00:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/2-penny-stocks-could-rally-163111780.html><strong>TipRanks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>At its January FOMC meeting, the Federal Reserve held interest rates steady – they are near rock-bottom now, and to no one’s surprise, the Fed is keeping them there.\nFed Chairman Jerome Powell may ...</p>\n\n<a href=\"https://finance.yahoo.com/news/2-penny-stocks-could-rally-163111780.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/94euyTCm3Fsmi1L1JkZXKQ--~B/aD00NTc7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/G1wIt1b2ALiEE..QV7lnrw--~B/aD00NTc7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/tipranks_452/24d79aa4d3847ec06a89abac7fdc7612","relate_stocks":{"BLRX":"BioLine Rx","KIN":"Kindred Biosciences, Inc."},"source_url":"https://finance.yahoo.com/news/2-penny-stocks-could-rally-163111780.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2107260553","content_text":"At its January FOMC meeting, the Federal Reserve held interest rates steady – they are near rock-bottom now, and to no one’s surprise, the Fed is keeping them there.\nFed Chairman Jerome Powell may have fed some market pessimism when he spoke after the meeting, and pointed out that unemployment, which has been rising in recent months. For market watchers seeking support, there is solace in the Fed’s monetary policy. The central bank is committed to buying $80 billion monthly in Treasury notes, and has put a rate increase on hold, likely until 2023.\nAt least one top strategist sees the current market environment in terms of opportunity. JPMorgan strategist Marko Kolanovic takes a bullish stance, writing, “We expect the global COVID pandemic to decline rapidly in the coming weeks. In fact, the pace of decline in new cases over the last 2 weeks is the highest on record both in the US and globally… Central Banks should remain accommodative given the elevated unemployment levels and over a decade of low inflation running below their targets… Short-term turmoil, such as the one this week, are opportunities to rotate from bonds to equities.”\nTaking this outlook into consideration, we set out to find exciting opportunities that won’t break the bank, namely penny stocks. These stocks, priced at $5 or less, offer investors some of the highest growth potential available in the market. There is risk here, too, as the ‘pennies’ are often priced low for a reason, so due diligence is essential.\nUsing TipRanks’ database, we identified two penny stocks that have earned a “Strong Buy” consensus rating from the analyst community. Not to mention each offers up massive upside potential, as some analysts seem them climbing to $11.\nBioLineRx, Ltd. (BLRX)\nWe’ll start with BioLineRx, a clinical stage biopharma company focused on developing new cancer treatments. Oncology is a major field for cutting edge biopharmas. Cancer is frequently deadly, and frequently resistant to current treatments – and those treatments themselves will frequently cause severe side effects in patients. BioLineRx has an active pipeline of drug candidates, but the most advanced is motixafortide, a synthetic peptide which has completed patient enrollment in a Phase 3 study on stem cell mobilization for autologous bone-marrow transplantation.\nThe drug is being studied for its efficacy in promoting the harvesting of bone marrow prior to the cancer treatment. Results from a pre-planned interim analysis showed ‘statistically significant evidence favoring treatment with motixafortide in the primary endpoint,’ evidence which was so significant that the enrollment was completed early, with 122 patients instead of 177. Stem cell mobilization, using motixafortide, is seen as the company’s most efficient path to registering the new drug for regulatory approval.\nBased on the potential of motixafortide and the $2.40 share price, some analysts think that now is the time to pull the trigger.\nCovering BLRX for Oppenheimer, 5-star analyst Mark Breidenbach noted, “Our thesis remains centered on motixafortide in stem cell mobilization, and we see a disconnect between the company’s market capitalization and motixafortide’s market opportunity as a stem cell mobilizer. Key GENESIS secondary endpoints are expected by mid-2021, and we see little risk heading into these data…”\nThe analyst added, “We believe results from the Phase 3 GENESIS trial could spur the majority of transplant physicians to choose BL-8040 over Mozobil to combine with G-CSF if the drug is approved. Upside to our thesis includes BL-8040 for use in other auto-HSCTs, allo-HSCTs, AML, and solid tumors. The company boasts a catalyst-rich, deep oncology pipeline that has attracted collaborations with Novartis, Merck, and Genentech.”\nGiven all of the above, Breidenbach rates BLRX as a Buy, and his $11 price target suggests a whopping 358% upside for the year ahead. (To watch Breidenbach’s track record, click here)\nThe rest of the Street appears to echo Breidenbach’s bullish sentiment. As it has racked up 3 Buys and no Holds or Sells, the consensus is unanimous: BLRX is a Strong Buy. Adding to the good news, the upside potential lands at ~428% based on the $12.67 average price target. (See BLRX stock analysis on TipRanks)\n\n\n\n\n\nKindred Biosciences (KIN)\nWhile most biotech companies focus on human medications, we are not the only market. Kindred biosciences is biopharmaceutical company in the veterinary market, developing biologic medications to improve the lives of our pets and working animals. The company describes its mission as ‘[bringing] to pets the same kinds of safe and effective medicines that human family members enjoy.’\nParvovirus (CPV) is a highly infectious, and highly lethal, viral disease affecting dogs. While vaccines are available, untreated cases can see upwards of 91% mortality. Kindred’s main pipeline drug, KIND-030 is under development as a treatment for this disease.\nCurrently, the drug candidate is following two paths in the development process – one for treatment of established infections, and one as a prophylactic preventative treatment for CPV. The prophylactic study has shown positive results, with treated dogs all avoiding infection, while all dogs in the placebo group developed parvovirus disease. KIND-030 also showed a mortality benefit when given as a treatment for infection. The drug candidate is in the pivotal study stage of development, the last before potential approval.\nLast month, Kindred announced that it had entered an agreement with Elanco Animal Health – a major manufacturer of veterinary medicines – for production of KIND-030.\nCantor analyst Brandon Folkes sees plenty of potential in Kindred, especially in the company’s agreement with Elanco.\n“A partnership with a leading animal health company, in this case Elanco, is exactly what the company needed, in our view. In our view, this validates KIN's new strategic approach, as a developer of drugs while seeking larger commercial partners. We believe that today's deal should reinforce to investors that there remains meaningful value in Kindred's pipeline, which could be realized over the next 12 to 18 months,” Folkes opined.\nKindred is also conducting studies of Tirnovetmab, or KIND-016, an antibody targeting IL31, in the treatment of atopic dermatitis in dogs. The pivotal efficacy study of this drug started in the last quarter of 2020. There is a potentially huge market for a successful dermatitis treatment for canines; in the last six years, there has been a 47% increase in vet visits for dogs with severe itchy skin, and the market is estimated at $900 million or more.\n“While 2020 has been a tough year for KIN stock, the company continues to have multiple shots on goal from its diversified pipeline that could reward investors from the current levels. With multiple readouts in 2021, and the renewed sole focus on development of its pipeline we expect 2021 could be a banner year for KIN should it be able to deliver on the promise of its pipeline, and in particular the atopic dermatitis portfolio,” the analyst summed up.\nTo this end, Folkes gives KIN an $11 price target, implying a 139% upside potential for 2021, and an Overweight (i.e. Buy) rating. (To watch Folkes’ track record, click here)\nKindred is another company with a unanimous Strong Buy analyst consensus, this one based on 5 recent Buy reviews. The stock has an average price target of $10.25, which suggests room for ~124% growth from the current trading price of $4.59. (See KIN stock analysis on TipRanks)\n\n\n\n\n\nTo find good ideas for penny stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.\nDisclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1516,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":393155907,"gmtCreate":1606265652809,"gmtModify":1703842128908,"author":{"id":"3464149602391943","authorId":"3464149602391943","name":"Dorash","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3464149602391943","idStr":"3464149602391943"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IBKR\">$盈透证券(IBKR)$</a>换了工作，结果绑的扣扣邮箱不能换手机号，因为手机已经注销了，然后年底想取钱，结果告知被冻结了，取不出来了。儿子叒生病了，不知道什么时候好，现在回了国外那边邮件，啥时候能把钱转出来呢！大家有这种情况吗？","listText":"<a href=\"https://laohu8.com/S/IBKR\">$盈透证券(IBKR)$</a>换了工作，结果绑的扣扣邮箱不能换手机号，因为手机已经注销了，然后年底想取钱，结果告知被冻结了，取不出来了。儿子叒生病了，不知道什么时候好，现在回了国外那边邮件，啥时候能把钱转出来呢！大家有这种情况吗？","text":"$盈透证券(IBKR)$换了工作，结果绑的扣扣邮箱不能换手机号，因为手机已经注销了，然后年底想取钱，结果告知被冻结了，取不出来了。儿子叒生病了，不知道什么时候好，现在回了国外那边邮件，啥时候能把钱转出来呢！大家有这种情况吗？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/393155907","isVote":1,"tweetType":1,"viewCount":3751,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3502195913108179","authorId":"3502195913108179","name":"武贤普","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":1,"authorIdStr":"3502195913108179","idStr":"3502195913108179"},"content":"转出来了吗","text":"转出来了吗","html":"转出来了吗"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":975665311,"gmtCreate":1600691907433,"gmtModify":1703822109336,"author":{"id":"3464149602391943","authorId":"3464149602391943","name":"Dorash","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3464149602391943","idStr":"3464149602391943"},"themes":[],"htmlText":"本来以为卖了美股就安全了，可是其他a股h也下跌啊","listText":"本来以为卖了美股就安全了，可是其他a股h也下跌啊","text":"本来以为卖了美股就安全了，可是其他a股h也下跌啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/975665311","repostId":"1124902004","repostType":4,"repost":{"id":"1124902004","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1600690926,"share":"https://www.laohu8.com/m/news/1124902004?lang=&edition=full","pubTime":"2020-09-21 20:22","market":"us","language":"zh","title":"盘前：道指期货跌2%！避险情绪升温，美股迎惊魂一夜","url":"https://stock-news.laohu8.com/highlight/detail?id=1124902004","media":"老虎资讯综合","summary":"9月21日（周一），美股三大指数期货全线下跌，道指期货跌近2%。【盘前行情】热门中概股热门中概股普跌，蔚来、理想、哔哩哔哩、百度、京东跌超2%、阿里跌1.62%。京东盘前跌超2%，子公司京东健康将","content":"<p>9月21日（周一），美股三大指数期货全线下跌，道指期货跌近2%。<img src=\"https://static.tigerbbs.com/a1d3b733b1c86c2bd82bc62553050761\" tg-width=\"1242\" tg-height=\"529\"></p><p><b>【盘前行情】</b></p><p><b>热门中概股</b></p><p>热门中概股普跌，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>、理想、<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>、<a href=\"https://laohu8.com/S/BIDU\">百度</a>、<a href=\"https://laohu8.com/S/JD\">京东</a>跌超2%、阿里跌1.62%。</p><p><a href=\"https://laohu8.com/S/JD\">京东</a>盘前跌超2%，子公司<a href=\"https://laohu8.com/S/JD\">京东</a>健康将于本周在港提交IPO，计划募资20亿美元，准确的募资金额将在聆讯后路演期间确定。按照港交所常规的上市进度来说，京东健康最快将于11月底在港交所敲钟。</p><p><a href=\"https://laohu8.com/S/DOYU\">斗鱼</a>盘前跌0.19%，<a href=\"https://laohu8.com/S/HUYA\">虎牙</a>盘前跌1.38%，<a href=\"https://laohu8.com/S/DOYU\">斗鱼</a><a href=\"https://laohu8.com/S/HUYA\">虎牙</a>合并前夕，<a href=\"https://laohu8.com/S/DOYU\">斗鱼</a>为转发攻击<a href=\"https://laohu8.com/S/HUYA\">虎牙</a>文章等行为道歉。此前，天眼查数据显示，近日，广州虎牙信息科技有限公司发生工商变更，变更项为股东、企业类型。其中，原股东广州华多网络科技有限公司、广州沁绿投资咨询有限公司退出，新增股东为林芝<a href=\"https://laohu8.com/S/00700\">腾讯</a>科技有限公司，持股比例为100%。同时，企业类型由其他有限责任公司变更为有限责任公司(法人独资)。</p><p><a href=\"https://laohu8.com/S/LEGN\">传奇生物</a>美股盘前跌近13%，其母公司金斯瑞生物疑因涉及违反进出口规定遭中国海关缉私部门搜查。</p><p><a href=\"https://laohu8.com/S/JOBS\">前程无忧</a>表示，其董事会已成立一个特别委员会，以评估其于9月17日收到的初步非约束性收购方案，以及其他潜在战略选择。公司表示，尚未就该提议做出决定。另，特别委员会包括两名独立董事。</p><p><b>重要美股</b></p><p>科技股方面，<a href=\"https://laohu8.com/S/AAPL\">苹果</a>盘前跌2.67%，<a href=\"https://laohu8.com/S/FB\">Facebook</a>盘前跌1.68%，<a href=\"https://laohu8.com/S/AMZN\">亚马逊</a>盘前跌1.89%，<a href=\"https://laohu8.com/S/MSFT\">微软</a>盘前跌2.29%。</p><p><a href=\"https://laohu8.com/S/ORCL\">甲骨文</a>盘前涨超7%，此前，字节跳动、<a href=\"https://laohu8.com/S/ORCL\">甲骨文</a>、<a href=\"https://laohu8.com/S/WMT\">沃尔玛</a>对TikTok的合作形成原则性共识。TikTok全球将由包括<a href=\"https://laohu8.com/S/ORCL\">甲骨文</a>和<a href=\"https://laohu8.com/S/WMT\">沃尔玛</a>在内的美国投资者持有多数股权。<a href=\"https://laohu8.com/S/WMT\">沃尔玛</a>同意收购拟成立的新公司TikTok全球7.5%的股份，首席执行官道格·麦克米伦也将成为这家新成立的公司的五名董事会成员之一。甲骨文和沃尔玛共同投资收购新成立的TikTok全球业务的20%。</p><p>Nikola盘前跌超22%，Nikola今日早前宣布，其创始人Trevor Milton自愿辞去执行董事长和董事会成员的职务。<a href=\"https://laohu8.com/S/GM\">通用汽车</a>前副董事长、Nikola董事会成员Stephen Girsky已被任命为公司董事长且已生效。此外，Trevor Milton同意与公司签订一份2年期、价值1000万美元的顾问协议，并向公司让渡包括其490万绩效股权在内的所有权益。</p><p><a href=\"https://laohu8.com/S/KODK\">柯达</a>盘前跌12%。全球性投资者权利律师事务所提醒，在2020年7月27号至2020年8月11日（包括“集体期限”）期间购买<a href=\"https://laohu8.com/S/KODK\">柯达</a>证券的人，该案件的主要原告截止日期是2020年10月13号。该诉讼寻求根据联邦证券法为<a href=\"https://laohu8.com/S/KODK\">柯达</a>投资者追回损失。</p><p>美股邮轮板块盘前普跌，<a href=\"https://laohu8.com/S/RCL\">皇家加勒比邮轮</a>、<a href=\"https://laohu8.com/S/CCL\">嘉年华邮轮</a>与<a href=\"https://laohu8.com/S/NCLH\">挪威邮轮</a>盘前均跌近5%，市场担忧新一轮疫情封锁将再重创邮轮行业。</p><p>美股石油股盘前走低。阿帕奇石油盘前跌2.45%，<a href=\"https://laohu8.com/S/TTA.UK\">道达尔</a>盘前跌3.06%，<a href=\"https://laohu8.com/S/OXY\">西方石油</a>盘前跌4.03%，荷兰皇家壳牌盘前跌3.08%，<a href=\"https://laohu8.com/S/BP\">英国石油</a>盘前跌3.5%。</p><p><a href=\"https://laohu8.com/S/QCOM\">高通</a>盘前跌1.66%，<a href=\"https://laohu8.com/S/ERIC\">爱立信</a>盘前跌近3%。日前，U.S.Cellular、<a href=\"https://laohu8.com/S/QCOM\">高通</a>和<a href=\"https://laohu8.com/S/ERIC\">爱立信</a>共同宣布，三方成功实现美国首次基于商用网络的增程毫米波5G NR 数据呼叫。此次具有里程碑意义的增程数据呼叫在威斯康星州简斯维尔市完成，通信距离超过5千米，速率超过100Mbps。此项成果打破了5G毫米波频谱仅适用于城市场景和高密度部署的传统观点，为利用现有基础设施扩大5G覆盖范围创造全新机遇。</p><p>纽蒙特矿业盘前跌1.55%，公司宣布将金矿特许使用权出售给Maverix公司，Maverix将以1500万美元现金、价值1200万美元的Maverix股权以及1500万美元浮动费用支付该笔费用。</p><p><b>财报预告：</b></p><p><a href=\"https://laohu8.com/S/NKE\">耐克</a>将在9月22日盘后发布2021财年第一财季业绩，这家运动服装和鞋类巨头预计将在2020财年结束后朝着恢复增长的方向取得进展。但在这个假日季及明年对价格更为敏感的购物环境下，该公司可能会如何表现，仍存在重大疑问。</p><p><b>【大宗商品】</b></p><ul><li>原油</li></ul><p>油价承压，WTI原油11月合约、布油现金11月合约均跌超2%。<img src=\"https://static.tigerbbs.com/df2a73d058744e3bf5f9265185167403\" tg-width=\"1242\" tg-height=\"945\"></p><ul><li>黄金</li></ul><p>黄金12月期货合约跌1.30%，报1936.5美元/盎司；白银期货合约跌2.3%报26.505美元/盎司。<img src=\"https://static.tigerbbs.com/36be261391cb5e8eebe75d16533a904b\" tg-width=\"1242\" tg-height=\"435\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>盘前：道指期货跌2%！避险情绪升温，美股迎惊魂一夜</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n盘前：道指期货跌2%！避险情绪升温，美股迎惊魂一夜\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2020-09-21 20:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>9月21日（周一），美股三大指数期货全线下跌，道指期货跌近2%。<img src=\"https://static.tigerbbs.com/a1d3b733b1c86c2bd82bc62553050761\" tg-width=\"1242\" tg-height=\"529\"></p><p><b>【盘前行情】</b></p><p><b>热门中概股</b></p><p>热门中概股普跌，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>、理想、<a href=\"https://laohu8.com/S/BILI\">哔哩哔哩</a>、<a href=\"https://laohu8.com/S/BIDU\">百度</a>、<a href=\"https://laohu8.com/S/JD\">京东</a>跌超2%、阿里跌1.62%。</p><p><a href=\"https://laohu8.com/S/JD\">京东</a>盘前跌超2%，子公司<a href=\"https://laohu8.com/S/JD\">京东</a>健康将于本周在港提交IPO，计划募资20亿美元，准确的募资金额将在聆讯后路演期间确定。按照港交所常规的上市进度来说，京东健康最快将于11月底在港交所敲钟。</p><p><a href=\"https://laohu8.com/S/DOYU\">斗鱼</a>盘前跌0.19%，<a href=\"https://laohu8.com/S/HUYA\">虎牙</a>盘前跌1.38%，<a href=\"https://laohu8.com/S/DOYU\">斗鱼</a><a href=\"https://laohu8.com/S/HUYA\">虎牙</a>合并前夕，<a href=\"https://laohu8.com/S/DOYU\">斗鱼</a>为转发攻击<a href=\"https://laohu8.com/S/HUYA\">虎牙</a>文章等行为道歉。此前，天眼查数据显示，近日，广州虎牙信息科技有限公司发生工商变更，变更项为股东、企业类型。其中，原股东广州华多网络科技有限公司、广州沁绿投资咨询有限公司退出，新增股东为林芝<a href=\"https://laohu8.com/S/00700\">腾讯</a>科技有限公司，持股比例为100%。同时，企业类型由其他有限责任公司变更为有限责任公司(法人独资)。</p><p><a href=\"https://laohu8.com/S/LEGN\">传奇生物</a>美股盘前跌近13%，其母公司金斯瑞生物疑因涉及违反进出口规定遭中国海关缉私部门搜查。</p><p><a href=\"https://laohu8.com/S/JOBS\">前程无忧</a>表示，其董事会已成立一个特别委员会，以评估其于9月17日收到的初步非约束性收购方案，以及其他潜在战略选择。公司表示，尚未就该提议做出决定。另，特别委员会包括两名独立董事。</p><p><b>重要美股</b></p><p>科技股方面，<a href=\"https://laohu8.com/S/AAPL\">苹果</a>盘前跌2.67%，<a href=\"https://laohu8.com/S/FB\">Facebook</a>盘前跌1.68%，<a href=\"https://laohu8.com/S/AMZN\">亚马逊</a>盘前跌1.89%，<a href=\"https://laohu8.com/S/MSFT\">微软</a>盘前跌2.29%。</p><p><a href=\"https://laohu8.com/S/ORCL\">甲骨文</a>盘前涨超7%，此前，字节跳动、<a href=\"https://laohu8.com/S/ORCL\">甲骨文</a>、<a href=\"https://laohu8.com/S/WMT\">沃尔玛</a>对TikTok的合作形成原则性共识。TikTok全球将由包括<a href=\"https://laohu8.com/S/ORCL\">甲骨文</a>和<a href=\"https://laohu8.com/S/WMT\">沃尔玛</a>在内的美国投资者持有多数股权。<a href=\"https://laohu8.com/S/WMT\">沃尔玛</a>同意收购拟成立的新公司TikTok全球7.5%的股份，首席执行官道格·麦克米伦也将成为这家新成立的公司的五名董事会成员之一。甲骨文和沃尔玛共同投资收购新成立的TikTok全球业务的20%。</p><p>Nikola盘前跌超22%，Nikola今日早前宣布，其创始人Trevor Milton自愿辞去执行董事长和董事会成员的职务。<a href=\"https://laohu8.com/S/GM\">通用汽车</a>前副董事长、Nikola董事会成员Stephen Girsky已被任命为公司董事长且已生效。此外，Trevor Milton同意与公司签订一份2年期、价值1000万美元的顾问协议，并向公司让渡包括其490万绩效股权在内的所有权益。</p><p><a href=\"https://laohu8.com/S/KODK\">柯达</a>盘前跌12%。全球性投资者权利律师事务所提醒，在2020年7月27号至2020年8月11日（包括“集体期限”）期间购买<a href=\"https://laohu8.com/S/KODK\">柯达</a>证券的人，该案件的主要原告截止日期是2020年10月13号。该诉讼寻求根据联邦证券法为<a href=\"https://laohu8.com/S/KODK\">柯达</a>投资者追回损失。</p><p>美股邮轮板块盘前普跌，<a href=\"https://laohu8.com/S/RCL\">皇家加勒比邮轮</a>、<a href=\"https://laohu8.com/S/CCL\">嘉年华邮轮</a>与<a href=\"https://laohu8.com/S/NCLH\">挪威邮轮</a>盘前均跌近5%，市场担忧新一轮疫情封锁将再重创邮轮行业。</p><p>美股石油股盘前走低。阿帕奇石油盘前跌2.45%，<a href=\"https://laohu8.com/S/TTA.UK\">道达尔</a>盘前跌3.06%，<a href=\"https://laohu8.com/S/OXY\">西方石油</a>盘前跌4.03%，荷兰皇家壳牌盘前跌3.08%，<a href=\"https://laohu8.com/S/BP\">英国石油</a>盘前跌3.5%。</p><p><a href=\"https://laohu8.com/S/QCOM\">高通</a>盘前跌1.66%，<a href=\"https://laohu8.com/S/ERIC\">爱立信</a>盘前跌近3%。日前，U.S.Cellular、<a href=\"https://laohu8.com/S/QCOM\">高通</a>和<a href=\"https://laohu8.com/S/ERIC\">爱立信</a>共同宣布，三方成功实现美国首次基于商用网络的增程毫米波5G NR 数据呼叫。此次具有里程碑意义的增程数据呼叫在威斯康星州简斯维尔市完成，通信距离超过5千米，速率超过100Mbps。此项成果打破了5G毫米波频谱仅适用于城市场景和高密度部署的传统观点，为利用现有基础设施扩大5G覆盖范围创造全新机遇。</p><p>纽蒙特矿业盘前跌1.55%，公司宣布将金矿特许使用权出售给Maverix公司，Maverix将以1500万美元现金、价值1200万美元的Maverix股权以及1500万美元浮动费用支付该笔费用。</p><p><b>财报预告：</b></p><p><a href=\"https://laohu8.com/S/NKE\">耐克</a>将在9月22日盘后发布2021财年第一财季业绩，这家运动服装和鞋类巨头预计将在2020财年结束后朝着恢复增长的方向取得进展。但在这个假日季及明年对价格更为敏感的购物环境下，该公司可能会如何表现，仍存在重大疑问。</p><p><b>【大宗商品】</b></p><ul><li>原油</li></ul><p>油价承压，WTI原油11月合约、布油现金11月合约均跌超2%。<img src=\"https://static.tigerbbs.com/df2a73d058744e3bf5f9265185167403\" tg-width=\"1242\" tg-height=\"945\"></p><ul><li>黄金</li></ul><p>黄金12月期货合约跌1.30%，报1936.5美元/盎司；白银期货合约跌2.3%报26.505美元/盎司。<img src=\"https://static.tigerbbs.com/36be261391cb5e8eebe75d16533a904b\" tg-width=\"1242\" tg-height=\"435\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","relate_stocks":{},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124902004","content_text":"9月21日（周一），美股三大指数期货全线下跌，道指期货跌近2%。【盘前行情】热门中概股热门中概股普跌，蔚来、理想、哔哩哔哩、百度、京东跌超2%、阿里跌1.62%。京东盘前跌超2%，子公司京东健康将于本周在港提交IPO，计划募资20亿美元，准确的募资金额将在聆讯后路演期间确定。按照港交所常规的上市进度来说，京东健康最快将于11月底在港交所敲钟。斗鱼盘前跌0.19%，虎牙盘前跌1.38%，斗鱼虎牙合并前夕，斗鱼为转发攻击虎牙文章等行为道歉。此前，天眼查数据显示，近日，广州虎牙信息科技有限公司发生工商变更，变更项为股东、企业类型。其中，原股东广州华多网络科技有限公司、广州沁绿投资咨询有限公司退出，新增股东为林芝腾讯科技有限公司，持股比例为100%。同时，企业类型由其他有限责任公司变更为有限责任公司(法人独资)。传奇生物美股盘前跌近13%，其母公司金斯瑞生物疑因涉及违反进出口规定遭中国海关缉私部门搜查。前程无忧表示，其董事会已成立一个特别委员会，以评估其于9月17日收到的初步非约束性收购方案，以及其他潜在战略选择。公司表示，尚未就该提议做出决定。另，特别委员会包括两名独立董事。重要美股科技股方面，苹果盘前跌2.67%，Facebook盘前跌1.68%，亚马逊盘前跌1.89%，微软盘前跌2.29%。甲骨文盘前涨超7%，此前，字节跳动、甲骨文、沃尔玛对TikTok的合作形成原则性共识。TikTok全球将由包括甲骨文和沃尔玛在内的美国投资者持有多数股权。沃尔玛同意收购拟成立的新公司TikTok全球7.5%的股份，首席执行官道格·麦克米伦也将成为这家新成立的公司的五名董事会成员之一。甲骨文和沃尔玛共同投资收购新成立的TikTok全球业务的20%。Nikola盘前跌超22%，Nikola今日早前宣布，其创始人Trevor Milton自愿辞去执行董事长和董事会成员的职务。通用汽车前副董事长、Nikola董事会成员Stephen Girsky已被任命为公司董事长且已生效。此外，Trevor Milton同意与公司签订一份2年期、价值1000万美元的顾问协议，并向公司让渡包括其490万绩效股权在内的所有权益。柯达盘前跌12%。全球性投资者权利律师事务所提醒，在2020年7月27号至2020年8月11日（包括“集体期限”）期间购买柯达证券的人，该案件的主要原告截止日期是2020年10月13号。该诉讼寻求根据联邦证券法为柯达投资者追回损失。美股邮轮板块盘前普跌，皇家加勒比邮轮、嘉年华邮轮与挪威邮轮盘前均跌近5%，市场担忧新一轮疫情封锁将再重创邮轮行业。美股石油股盘前走低。阿帕奇石油盘前跌2.45%，道达尔盘前跌3.06%，西方石油盘前跌4.03%，荷兰皇家壳牌盘前跌3.08%，英国石油盘前跌3.5%。高通盘前跌1.66%，爱立信盘前跌近3%。日前，U.S.Cellular、高通和爱立信共同宣布，三方成功实现美国首次基于商用网络的增程毫米波5G NR 数据呼叫。此次具有里程碑意义的增程数据呼叫在威斯康星州简斯维尔市完成，通信距离超过5千米，速率超过100Mbps。此项成果打破了5G毫米波频谱仅适用于城市场景和高密度部署的传统观点，为利用现有基础设施扩大5G覆盖范围创造全新机遇。纽蒙特矿业盘前跌1.55%，公司宣布将金矿特许使用权出售给Maverix公司，Maverix将以1500万美元现金、价值1200万美元的Maverix股权以及1500万美元浮动费用支付该笔费用。财报预告：耐克将在9月22日盘后发布2021财年第一财季业绩，这家运动服装和鞋类巨头预计将在2020财年结束后朝着恢复增长的方向取得进展。但在这个假日季及明年对价格更为敏感的购物环境下，该公司可能会如何表现，仍存在重大疑问。【大宗商品】原油油价承压，WTI原油11月合约、布油现金11月合约均跌超2%。黄金黄金12月期货合约跌1.30%，报1936.5美元/盎司；白银期货合约跌2.3%报26.505美元/盎司。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1841,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":956339198,"gmtCreate":1591574003714,"gmtModify":1704195947188,"author":{"id":"3464149602391943","authorId":"3464149602391943","name":"Dorash","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3464149602391943","idStr":"3464149602391943"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01317\">$枫叶教育(01317)$</a>不错不错，值得关注！","listText":"<a href=\"https://laohu8.com/S/01317\">$枫叶教育(01317)$</a>不错不错，值得关注！","text":"$枫叶教育(01317)$不错不错，值得关注！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/956339198","isVote":1,"tweetType":1,"viewCount":1395,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":913607539,"gmtCreate":1577490143321,"gmtModify":1704335885707,"author":{"id":"3464149602391943","authorId":"3464149602391943","name":"Dorash","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3464149602391943","idStr":"3464149602391943"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>买这种股票到底是图啥？大资金会来解放我们吗？现在市场管制，突然业绩爆发可能性没有，然后美股年年新高，抄底资金没有，周期高点啊！哪个高手谈下买入理由！","listText":"<a href=\"https://laohu8.com/S/TIGR\">$老虎证券(TIGR)$</a>买这种股票到底是图啥？大资金会来解放我们吗？现在市场管制，突然业绩爆发可能性没有，然后美股年年新高，抄底资金没有，周期高点啊！哪个高手谈下买入理由！","text":"$老虎证券(TIGR)$买这种股票到底是图啥？大资金会来解放我们吗？现在市场管制，突然业绩爆发可能性没有，然后美股年年新高，抄底资金没有，周期高点啊！哪个高手谈下买入理由！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/913607539","isVote":1,"tweetType":1,"viewCount":2966,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3516879098555470","authorId":"3516879098555470","name":"Shuangying","avatar":"https://static.tigerbbs.com/56caaec948915f9f1a3b4e3491ac5861","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3516879098555470","idStr":"3516879098555470"},"content":"那么多好股票不做，偏偏做多老虎，我也是醉了","text":"那么多好股票不做，偏偏做多老虎，我也是醉了","html":"那么多好股票不做，偏偏做多老虎，我也是醉了"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":910518949,"gmtCreate":1576044352981,"gmtModify":1704271128751,"author":{"id":"3464149602391943","authorId":"3464149602391943","name":"Dorash","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3464149602391943","idStr":"3464149602391943"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/00763\">$中兴通讯(00763)$</a>同为5g概念你为啥不知道涨？看看人家立讯精密！！！","listText":"<a href=\"https://laohu8.com/S/00763\">$中兴通讯(00763)$</a>同为5g概念你为啥不知道涨？看看人家立讯精密！！！","text":"$中兴通讯(00763)$同为5g概念你为啥不知道涨？看看人家立讯精密！！！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/910518949","isVote":1,"tweetType":1,"viewCount":3050,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3537045207544484","authorId":"3537045207544484","name":"27个优质股","avatar":"https://static.tigerbbs.com/fde1daa28cae792e520759bac55bcdd3","crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3537045207544484","idStr":"3537045207544484"},"content":"大家的所属领域不同，立讯精密是零配件处在行业的顶端，中兴通讯是成品是通信应用处于行业的中游","text":"大家的所属领域不同，立讯精密是零配件处在行业的顶端，中兴通讯是成品是通信应用处于行业的中游","html":"大家的所属领域不同，立讯精密是零配件处在行业的顶端，中兴通讯是成品是通信应用处于行业的中游"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":910599969,"gmtCreate":1576035300951,"gmtModify":1704271093586,"author":{"id":"3464149602391943","authorId":"3464149602391943","name":"Dorash","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3464149602391943","idStr":"3464149602391943"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01810\">$小米集团-W(01810)$</a>这种好的有业绩的还有利润的，还是知名的，还在增长的，腰斩就是黄金坑啊！","listText":"<a href=\"https://laohu8.com/S/01810\">$小米集团-W(01810)$</a>这种好的有业绩的还有利润的，还是知名的，还在增长的，腰斩就是黄金坑啊！","text":"$小米集团-W(01810)$这种好的有业绩的还有利润的，还是知名的，还在增长的，腰斩就是黄金坑啊！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/910599969","isVote":1,"tweetType":1,"viewCount":3001,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":910208675,"gmtCreate":1575964746197,"gmtModify":1704730216785,"author":{"id":"3464149602391943","authorId":"3464149602391943","name":"Dorash","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3464149602391943","idStr":"3464149602391943"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01810\">$小米集团-W(01810)$</a>K30在哪里买啊？官网还看不到！","listText":"<a href=\"https://laohu8.com/S/01810\">$小米集团-W(01810)$</a>K30在哪里买啊？官网还看不到！","text":"$小米集团-W(01810)$K30在哪里买啊？官网还看不到！","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/910208675","isVote":1,"tweetType":1,"viewCount":2169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"followers","isTTM":false}